Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023

Rhea-AI Summary

Option Care Health, Inc. (OPCH) reported strong financial results for Q4 and full year 2023, with net revenue reaching $1,124.4 million and $4,302.3 million, respectively. The company saw increases in gross profit, net income, adjusted EBITDA, and cash flow from operations. Share repurchases totaling $250 million were fulfilled, with an additional $250 million authorized. CEO John C. Rademacher highlighted the focus on clinical excellence and patient care. The company provided financial guidance for 2024, expecting net revenue of $4.6 billion to $4.8 billion, adjusted EBITDA of $425 million to $450 million, and cash flow from operations of at least $300 million.

Positive

• Strong financial results for Option Care Health in Q4 and full year 2023.
• Net revenue for Q4 reached $1,124.4 million, up 9.5% compared to the previous year.
• Full year 2023 net revenue was $4,302.3 million, up 9.1% compared to 2022.
• Gross profit, net income, adjusted EBITDA, and cash flow from operations all showed positive growth.
• Share repurchases of $250 million were fulfilled, with an additional $250 million authorized.
• CEO emphasized commitment to clinical excellence and patient care.
• Financial guidance for 2024 includes net revenue of $4.6 billion to $4.8 billion, adjusted EBITDA of $425 million to $450 million, and cash flow from operations of at least $300 million.

Negative

• None.

Insights

Financial Analyst

Option Care Health's Q4 and full year financial results exhibit a robust performance, signaling a positive outlook for stakeholders. The 9.5% year-over-year increase in Q4 net revenue and the 9.1% uptick for the full year are indicative of the company's ability to expand its market share in the home and alternate site infusion services industry. Furthermore, the 18.4% rise in adjusted EBITDA for Q4 and a 24.0% hike for the full year suggest operational efficiency and improved profitability margins, which are essential metrics for investor confidence.

Additionally, the significant increase in cash flow from operations, up by 38.8%, provides the company with ample liquidity to support ongoing operations and strategic initiatives. The $250 million share repurchase fulfillment, coupled with a new authorization for an equivalent amount, reflects the management's confidence in the company's valuation and future performance. These buybacks could potentially lead to earnings per share accretion and underline a shareholder-friendly capital allocation policy.

Market Research Analyst

The healthcare sector, particularly home and alternate site infusion services, is experiencing growing demand due to the aging population and a shift towards more cost-effective treatment options outside traditional hospital settings. Option Care Health's strategic positioning as the largest independent provider in this space allows it to capitalize on these industry trends. The company's focus on clinical excellence and patient-centered care, as highlighted by the CEO, is a competitive differentiator that may contribute to customer loyalty and sustained revenue growth.

Looking ahead, the projected net revenue range of $4.6 billion to $4.8 billion for FY 2024 suggests an aggressive growth strategy. This forecast, along with the anticipated adjusted EBITDA and operational cash flow, indicates that Option Care Health is not only maintaining but also potentially increasing its market leadership amid a competitive landscape.

Healthcare Industry Analyst

Option Care Health's financial results reflect the inherent resilience and scalability of their business model. The infusion services sector is increasingly integral to healthcare delivery and the company's national platform positions it well to navigate reimbursement challenges and regulatory changes. The rise in gross profit, despite a slight decrease in gross margin percentage, implies effective cost management and pricing strategies.

The effective tax rate guidance for 2024 falls within a standard range for U.S. corporations, suggesting no abnormal tax positions that might concern investors. The projected net interest expense indicates manageable debt levels relative to earnings, which is crucial for long-term financial stability. However, investors should monitor how the company balances growth investments with debt servicing to maintain financial health.

BANNOCKBURN, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023.

Fourth Quarter 2023 Financial Highlights

• Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022
• Gross profit of $247.1 million, or 22.0% of revenue, up 6.9% compared to $231.1 million, or 22.5% of revenue, in the fourth quarter of 2022
• Net income of $57.2 million, or $0.32 earnings per share, inclusive of the impact from non-operating income, compared to net income of $47.5 million, or $0.26 earnings per share in the fourth quarter of 2022
• Adjusted EBITDA of $111.6 million, up 18.4% compared to $94.3 million in the fourth quarter of 2022
• Cash flow from operations of $51.0 million, and cash balances of $343.8 million at the end of the fourth quarter
• The Company announced that it fulfilled $250 million in share repurchases and the Board of Directors authorized an additional $250 million share repurchase authorization

Full Year 2023 Financial Highlights

• Net revenue of $4,302.3 million, up 9.1% compared to $3,944.7 million in full year 2022
• Gross profit of $981.2 million, or 22.8% of revenue, up 13.2% compared to $866.9 million, or 22.0% of revenue, in full year 2022
• Net income of $267.1 million, or $1.48 diluted earnings per share, compared to net income of $150.6 million, or $0.83 earnings per share, in full year 2022
• Adjusted EBITDA of $425.2 million, up 24.0% compared to $342.9 million in full year 2022
• Cash flow from operations of $371.3 million, up 38.8% compared to $267.5 million in full year 2022
  

John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team delivered strong financial results in the fourth quarter and full year of 2023 and continued to execute on our commitment to clinical excellence by providing extraordinary patient care through our resilient national platform. The patient is at the center of everything we do, and I am excited to build on this momentum in 2024 to further our mission to provide innovative services that improve outcomes, reduce costs, and deliver hope for patients and families.”

Full Year 2024 Financial Guidance

For the full year 2024, Option Care Health expects to deliver the following financial results:

• Net revenue of $4.6 billion to $4.8 billion
• Adjusted EBITDA of $425 million to $450 million
• Cash flow from operations of at least $300 million
  

Additionally, the Company anticipates an effective tax rate of 26% - 28% and net interest expense of approximately $55 million to $60 million.

Conference Call

Option Care Health will host a conference call to discuss its financial results later today at 8:30 a.m. EST. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,500 team members, including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates. To learn more, please visit our website at OptionCareHealth.com.

Investor Contacts

Mike Shapiro	Bob East, Asher Dewhurst, Jordan Kohnstam
Chief Financial Officer	Westwicke
T: (312) 940-2538	T: (413) 213-0500
mike.shapiro@optioncare.com	optioncarehealth@westwicke.com

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our services and offerings; pending and future litigation; potential liability for claims not covered by insurance; and loss of relationships with managed care organizations and other non-governmental third party payers. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our periodic reports as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Note Regarding Use of Non-GAAP Financial Measures

In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is not a measurement of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, operating income or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definition of Adjusted EBITDA may not be comparable to similarly titled non-GAAP financial measures reported by other companies. Adjusted EBITDA, as defined by the Company, represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other. As part of restructuring, acquisition, integration and other, the Company may incur significant charges such as the write down of certain long‑lived assets, temporary redundant expenses, professional fees, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that Adjusted EBITDA provides useful supplemental information regarding the performance of Option Care Health’s business operations and facilitates comparisons to the Company’s historical operating results. We have not reconciled Adjusted EBITDA guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. For a full reconciliation of Adjusted EBITDA to the most comparable GAAP financial measure, please see below.

  Schedule 1

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)(UNAUDITED)

	December 31,
		2023			2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	343,849		$	294,186
Accounts receivable, net		377,658			377,542
Inventories		274,004			224,281
Prepaid expenses and other current assets		98,744			98,330
Total current assets		1,094,255			994,339
NONCURRENT ASSETS:
Property and equipment, net		120,630			108,321
Intangible assets, net		20,092			22,371
Referral sources, net		315,304			341,744
Goodwill		1,540,246			1,533,424
Other noncurrent assets		126,508			112,737
Total noncurrent assets		2,122,780			2,118,597
TOTAL ASSETS	$	3,217,035		$	3,112,936
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	426,513		$	378,763
Other current liabilities		191,796			186,588
Total current liabilities		618,309			565,351
NONCURRENT LIABILITIES:
Long-term debt, net of discount, deferred financing costs and current portion		1,056,650			1,058,204
Other noncurrent liabilities		120,404			103,278
Total noncurrent liabilities		1,177,054			1,161,482
Total liabilities		1,795,363			1,726,833
STOCKHOLDERS' EQUITY		1,421,672			1,386,103
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	3,217,035		$	3,112,936

Schedule 2

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)

	Three Months Ended December 31,								Year Ended December 31,
		2023				2022				2023				2022
NET REVENUE	$	1,124,390			$	1,027,213			$	4,302,324			$	3,944,735
COST OF REVENUE		877,267				796,132				3,321,101				3,077,817
GROSS PROFIT		247,123				231,081				981,223				866,918
OPERATING COSTS AND EXPENSES:
Selling, general and administrative expenses		147,783				148,351				607,427				566,122
Depreciation and amortization expense		14,784				14,538				59,201				60,565
Total operating expenses		162,567				162,889				666,628				626,687
OPERATING INCOME		84,556				68,192				314,595				240,231
OTHER INCOME (EXPENSE):
Interest expense, net		(12,432	)			(14,798	)			(51,248	)			(53,806	)
Other, net		6,801				11,387				95,395				19,343
Total other (expense) income		(5,631	)			(3,411	)			44,147				(34,463	)
INCOME BEFORE INCOME TAXES		78,925				64,781				358,742				205,768
INCOME TAX EXPENSE		21,748				17,252				91,652				55,212
NET INCOME	$	57,177			$	47,529			$	267,090			$	150,556
Earnings per share, basic	$	0.32			$	0.26			$	1.49			$	0.83
Earnings per share, diluted	$	0.32			$	0.26			$	1.48			$	0.83
Weighted average common shares outstanding, basic		176,055				181,925				178,973				181,105
Weighted average common shares outstanding, diluted		177,743				183,086				180,375				182,075

Schedule 3

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)(UNAUDITED)

	Year Ended December 31,
		2023				2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	267,090			$	150,556
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization expense		62,200				65,434
Deferred income taxes - net		12,766				49,187
Other non-cash adjustments		50,684				32,147
Changes in operating assets and liabilities:
Accounts receivable, net		224				(36,889	)
Inventories		(51,000	)			(41,010	)
Accounts payable		47,703				98,885
Other		(18,372	)			(50,763	)
Net cash provided by operating activities		371,295				267,547
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of property and equipment		(41,866	)			(35,358	)
Proceeds from sale of assets		3,743				14,670
Business acquisitions, net of cash acquired		(12,494	)			(87,364	)
Other investing activities		(5,889	)			—
Net cash used in investing activities		(56,506	)			(108,052	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from warrant exercises		—				20,916
Purchase of company stock		(250,261	)			—
Other financing activities		(14,865	)			(5,648	)
Net cash (used in) provided by financing activities		(265,126	)			15,268
NET INCREASE IN CASH AND CASH EQUIVALENTS		49,663				174,763
Cash and cash equivalents - beginning of the period		294,186				119,423
CASH AND CASH EQUIVALENTS - END OF PERIOD	$	343,849			$	294,186

Schedule 4

OPTION CARE HEALTH, INC.
RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES
(IN THOUSANDS)(UNAUDITED)

	Three Months Ended   December 31,								Year Ended December 31,
		2023				2022				2023				2022
Net income	$	57,177			$	47,529			$	267,090			$	150,556
Interest expense, net		12,432				14,798				51,248				53,806
Income tax expense		21,748				17,252				91,652				55,212
Depreciation and amortization expense		15,777				15,711				62,200				65,434
EBITDA		107,134				95,290				472,190				325,008
EBITDA adjustments
Stock-based incentive compensation expense		7,571				4,202				30,479				16,783
Gain on sale of assets		—				(10,325	)			—				(10,325	)
Restructuring, acquisition, integration and other (1)		(3,103	)			5,105				(77,486	)			11,387
Adjusted EBITDA	$	111,602			$	94,272			$	425,183			$	342,853

(1) Restructuring, acquisition, integration and other for the year ended December 31, 2023 includes the Amedisys merger termination fee, net of merger-related expenses

FAQ

What was Option Care Health's (OPCH) net revenue for Q4 2023?

Option Care Health reported net revenue of $1,124.4 million for Q4 2023, showing a 9.5% increase compared to the previous year.

How much were the share repurchases fulfilled by Option Care Health (OPCH)?

Option Care Health fulfilled $250 million in share repurchases and authorized an additional $250 million.

What financial guidance did Option Care Health (OPCH) provide for full year 2024?

Option Care Health expects net revenue of $4.6 billion to $4.8 billion, adjusted EBITDA of $425 million to $450 million, and cash flow from operations of at least $300 million for full year 2024.

When will Option Care Health (OPCH) host a conference call to discuss its financial results?

Option Care Health will host a conference call to discuss its financial results later today at 8:30 a.m. EST.

Where can the conference call of Option Care Health (OPCH) be accessed?

The conference call can be accessed via a live audio webcast available online at investors.optioncarehealth.com.

How long will the replay of Option Care Health's (OPCH) conference call be available for on-demand listening?

The replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.